SQZ Biotechnologies Company

SQZ Biotechnologies Companyverified

SQZ

Price:

$0.435

Market Cap:

$811.00K

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations wi...[Read more]

Industry

Biotechnology

IPO Date

2020-10-30

Stock Exchange

NYSE

Ticker

SQZ

The Current Ratio as of December 2024 (TTM) for SQZ Biotechnologies Company (SQZ) is 1.37

According to SQZ Biotechnologies Company’s latest financial reports and current stock price. The company's current Current Ratio is 1.37. This represents a change of -49.25% compared to the average of 2.70 of the last 4 quarters.

SQZ Biotechnologies Company (SQZ) Historical Current Ratio (quarterly & annually)

How has SQZ Current Ratio performed in the past?

The mean historical Current Ratio of SQZ Biotechnologies Company over the last ten years is 3.87. The current 1.37 Current Ratio has changed 3.44% with respect to the historical average. Over the past ten years (40 quarters), SQZ's Current Ratio was at its highest in in the December 2021 quarter at 4.53. The Current Ratio was at its lowest in in the September 2023 quarter at 1.37.

Quarterly (TTM)
Annual

Average

3.87

Median

3.91

Minimum

2.66

Maximum

5.10

SQZ Biotechnologies Company (SQZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SQZ Biotechnologies Company Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 47.12%

Maximum Annual Current Ratio = 5.10

Minimum Annual Increase = -47.87%

Minimum Annual Current Ratio = 2.66

Quarterly (TTM)
Annual
YearCurrent RatioChange
20223.12-31.13%
20214.5315.87%
20203.9147.12%
20192.66-47.87%

SQZ Biotechnologies Company (SQZ) Average Current Ratio

How has SQZ Current Ratio performed in the past?

The current Current Ratio of SQZ Biotechnologies Company (SQZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.86

5-year avg

3.87

10-year avg

3.87

SQZ Biotechnologies Company (SQZ) Current Ratio vs. Peers

How is SQZ’s Current Ratio compared to its peers?

SQZ Biotechnologies Company’s Current Ratio is less than AN2 Therapeutics, Inc. (9.75), less than Miromatrix Medical Inc. (3.46), greater than Inhibikase Therapeutics, Inc. (0.85), less than PMV Pharmaceuticals, Inc. (13.98), less than Anebulo Pharmaceuticals, Inc. (3.45), greater than Comera Life Sciences Holdings, Inc. (0.90), less than SAB Biotherapeutics, Inc. (3.69), less than Processa Pharmaceuticals, Inc. (3.97), less than Fresh Tracks Therapeutics, Inc. (6.98), less than Third Harmonic Bio, Inc. (42.50), less than Lipella Pharmaceuticals Inc. (2.97K), less than Senti Biosciences, Inc. (1.92), less than Fennec Pharmaceuticals Inc. (7.80), less than Monopar Therapeutics Inc. (5.41), less than Applied Molecular Transport Inc. (4.99), less than Neoleukin Therapeutics, Inc. (15.33), less than Hillstream BioPharma, Inc. (2.25), less than Quoin Pharmaceuticals, Ltd. (3.02), greater than Candel Therapeutics, Inc. (1.18), less than Werewolf Therapeutics, Inc. (10.10), less than Kezar Life Sciences, Inc. (7.65), less than Nuvation Bio Inc. (9.57),

Build a custom stock screener for SQZ Biotechnologies Company (SQZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SQZ Biotechnologies Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SQZ Biotechnologies Company (SQZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SQZ Biotechnologies Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is SQZ Biotechnologies Company's Current Ratio?

How is the Current Ratio calculated for SQZ Biotechnologies Company (SQZ)?

What is the highest Current Ratio for SQZ Biotechnologies Company (SQZ)?

What is the 3-year average Current Ratio for SQZ Biotechnologies Company (SQZ)?

What is the 5-year average Current Ratio for SQZ Biotechnologies Company (SQZ)?

How does the current Current Ratio for SQZ Biotechnologies Company (SQZ) compare to its historical average?